Effects of serum containing Tanyu Tongzhi formula on production of NO, caveolin-1 and eNOS in HUVECs injured by ox-LDL

Zhongguo Zhongyao Zazhi

Volumn 37, Issue 7, 2012, Pages 974-978

  Ma, Yueying ^a   Liu, Jianxun ^a   Li, Peng ^a   Zhu, Sheng ^a   Lin, Chengren ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Artherosclerosis; Caveolin 1; Endothelial nitricoxide synthase; Nitric oxide; Tanyu Tongzhi formula; Vascular endothelial cell

Indexed keywords

CAVEOLIN 1; CHINESE DRUG; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SIMVASTATIN; TANYU TONGZHI FORMULA; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; DRUG BLOOD LEVEL; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANIMALS; CAVEOLIN 1; CELL LINE; DRUGS, CHINESE HERBAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; SERUM;

EID: 84862744619     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20120723     Document Type: Article

References (8)

1. Paul L Huang. eNOS, metabolic syndrome and cardiovascular disease[J]. Trends Endocrin Met, 2009,20(6):295.
2. A Sharma, C Yu, Bernatchez. New insights into caveolae, caveolins and endothelial function[J]. Can J Cardiol, 2010,26(Suppl A):5A.
3. Zulli A, Buxton B F, Black M J, et al. The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels[J]. J Histochem Cytochem, 2006,54(2):151.
4. Du Y H, Chen A F. A new role for caveolin-1: regulation of guanosine triphosphate cyclohydrolase I and tetrahydrobiopterin in endothelial cells[J]. Hypertension, 2009,53(2):115.
5. Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice[J]. Science, 2001,293(28):2449.